comparemela.com

Latest Breaking News On - ஊ சிமோன் விரிவான புற்றுநோய் மையம் - Page 1 : comparemela.com

IU researcher uncovers potential new approach for treating pancreatic cancer

IU School of Medicine scientists discover game-changer treatment for triple negative breast cancer

Date Time IU School of Medicine scientists discover ‘game-changer’ treatment for triple negative breast cancer The new precision immunotherapy for triple negative breast cancer was developed from a mushroom toxin. Image courtesy of Xiongbin Lu A team of Indiana University School of Medicine researchers has developed a novel antibody-drug conjugate for treating triple negative breast cancer. The study, led by senior author Xiongbin Lu, Vera Bradley Foundation Professor of Breast Cancer Innovation at the IU School of Medicine, has been published in the prestigious interdisciplinary medical journal, Science Translational Medicine. Triple negative breast cancer accounts for about 15 percent of all breast cancer cases. When a patient tests negative for estrogen receptors and progesterone receptors and has low levels of a protein called HER2, the patient is considered to have “triple negative” breast cancer. Patients with triple negative breast cancer typically have the poores

World Cancer Day: Cancer Pain Ravages Lives amidst Pandemic Challenges

Rose Kiwanuka, cancer survivor and palliative care advocate Nearly 2 of every 3 people diagnosed with advanced cancer around the world do not have access to essential medicines for relief of moderate to severe pain. I felt the world had crumpled on me. I needed people to talk to, to support me, to explain what was happening. To relieve my pain. So palliative care has been playing a very big role in my life.” Rose Kiwanuka, cancer survivor and palliative care advocate INDIANAPOLIS, INDIANA, UNITED STATES, February 3, 2021 /EINPresswire.com/ When 60-year old Rose Kiwanuka, was diagnosed with advanced cancer three years ago in Kampala, Uganda, she needed two things.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.